AIDS Weekly articles from November 1992

AIDS Weekly archives from November 1992

New acyclovir prodrug holds promise for herpes treatment. (Fifteenth AIDS Clinical Trials Group meeting)
November 30, 1992... DATELINE: Fifteenth AIDS Clinical Trials Group Meeting A new oral medication yields serum levels of the anti-herpesvirus drug acyclovir previously attainable only by intravenous injection, according to a report at the AIDS Clinical...

Non-compliance of TB therapy addressed. (World Congress on Tuberculosis)
November 30, 1992... DATELINE: World Congress on Tuberculosis New strains of tuberculosis attacking AIDS patients can kill in a matter of weeks, and one expert in the field suggests that people refusing tuberculosis (TB) treatment should be quarantined. ...

Dynagen presents data on advanced mycobacterial diagnostic tests. (World Congress on Tuberculosis)
November 30, 1992... DATELINE: World Congress on Tuberculosis At the World Congress on Tuberculosis, held November 16-19, 1992, in Bethesda, Maryland, DynaGen Inc. scientists presented data on two advanced tests for detecting mycobacterial diseases such as...

Hospital AIDS fatalities linked to facility's previous experience.
November 30, 1992... DATELINE: United States Patients with AIDS are more than twice as likely to die while being treated in hospitals having little experience with the disease as in those having a lot, a new study has found. "It may be because of...

Applied Immune Sciences and Dutch company to build first cell processing center in Middle East. (Eriphyle BV, Applied Cell Care Ltd., to be located in Israel) (The Netherlands)
November 30, 1992... DATELINE: The Netherlands Applied Immune Sciences Inc. (AIS), Santa Clara, California, and Netherlands-based Eriphyle BV announced a joint venture to build the first cell therapy center based in the Middle East. The center, to be...

Survey of 1050 U.S. cities shows wide rate variation of small group health insurance premiums. (Milliman & Robertson Inc., New York)
November 30, 1992... DATELINE: New York With an average monthly rate of $668, Los Angeles leads the nation in premium rates for a typical package of group health insurance benefits, according to a new survey of 1050 American cities by Milliman & Robertson...

New AIDS disability rule may come soon. (National Commission on AIDS)
November 30, 1992... DATELINE: National Commission on AIDS New regulations that could speed Social Security disability benefits to people infected with HIV probably will be issued before the Bush administration leaves office, officials indicated at the...

Chairman of AmFAR speaks out. (Dr. Mathilde Krim; American Foundation for AIDS Research) (National Commission on AIDS)
November 30, 1992... DATELINE: National Commission on AIDS Dr. Mathilde Krim, chairman of the American Foundation for AIDS Research (AmFAR) called on the incoming Clinton administration to lift the bans on homosexuals serving in the military and those...

Governments slow to confront AIDS epidemic in South Asia. (Second International Congress on AIDS in Asia, New Delhi, India)
November 30, 1992... DATELINE: India South Asia's efforts to control the spread of HIV may be stymied by political indifference and socio-religious norms, warn experts attending the Second International Congress on AIDS in Asia, held in New Delhi, India,...

AIDS awareness campaign must involve women, say experts. (Second International Congress on AIDS in Asia, New Delhi, India)
November 30, 1992... DATELINE: India AIDS has often been described as an "equal opportunity disease" but more and more experts are veering to the view that women are the most susceptible to HIV. "HIV mirrors the true status of women in society today,"...

Indian AIDS program is lopsided, says expert. (Ishwar S. Gilada) (Second International Congress on AIDS in Asia, New Delhi, India)
November 30, 1992... DATELINE: India Are consultants more effective than condoms in checking the rapid transmission of HIV? The Indian government seems to think so, says a doctor attending the Second International Congress on AIDS in Asia, held in New...

'Intentional spreading of HIV' law challenged. (Louisiana)
November 30, 1992... DATELINE: Louisiana Twenty-five states outlaw passing or purposely exposing others to HIV, but only recently have such laws been invoked and now a Louisiana case is receiving what may be their first constitutional challenge. As...

Organization using "supermodel" for fund-raising efforts. (Linda Evangelista) (Pediatric AIDS Foundation)
November 30, 1992... DATELINE: Pediatric AIDS Foundation Supermodel Linda Evangelista's latest billboard isn't a pitch for clothing or cosmetics, but a fund-raising plea for the Pediatric AIDS Foundation. The group's founder, Elizabeth Glaser, and...

Global analysis of HIV/AIDS published. ("AIDS in the World," produced by the Global AIDS Policy Coalition) (Harvard School of Public Health)
November 30, 1992... DATELINE: Harvard School of Public Health "AIDS in the World," has recently been produced by the Global AIDS Policy Coalition (GAPC). The GAPC is an independent nongovernmental organization based at Harvard University, Cambridge,...

Company develops novel mapping system for complex carbohydrates. (Oxford GlycoSystems)
November 30, 1992... DATELINE: Oxford GlycoSystems Oxford GlycoSystems (OGS), Oxford, England, announced it has developed an innovative instrument system to map oligosaccharides, a class of molecules commonly known as complex carbohydrates. The...

Evaluation of an indirect immunofluorescence assay for the confirmation of HIV-1 antibody in U.S. blood donor sera. (Research Report)
November 30, 1992... AUTHORS: M. Sullivan, H. Mucke. S. Kadey, C. Fang and A. Williams. American Red Cross Holland Lab, Rockville, Maryland, and Waldheim Pharmazeutika, Vienna, Austria. According to the authors' abstract submitted to the 45th Annual...

Development of an immunoblot assay for detection of antibody to human immunodeficiency virus type 2. (Research Report)
November 30, 1992... AUTHORS: M. Alsup, K. Brackmann, P. Stewart and K. Shriver. Genetic Systems Corporation, Redmond, Washington. According to the authors' abstract submitted to the 45th Annual Meeting of the American Association of Blood Banks, held in...

Inactivation of free and cell-associated HIV in platelet suspensions by aminomethyltri-methylpsoralen (AMT) and ultraviolet light. (Research Report)
November 30, 1992... AUTHORS: L.E. Benade, J. Shumaker, Y. Xu and R. Dodd. American Red Cross, Rockville, Maryland. According to the authors' abstract submitted to the 45th Annual Meeting of the American Association of Blood Banks, held in San Francisco,...

Monospecific polyclonal reactivity to HIV-1 gp41 as the cause of HIV-1 Western blot false positive test. (Research Report)
November 30, 1992... AUTHORS: K. Sayre, G. Tegtmeier, W. Bayer and S. Alexander. Ortho Diagnostic Systems Inc., Raritan, New Jersey, Community Blood Center of Greater Kansas City, Kansas City, Missouri, and Cambridge Biotech Corporation, Rockville, Maryland....

Searching for patients coinfected with HIV and M. tuberculosis among clients of an inner city methadone clinic. (Mycobacterium tuberculosis) (Research Report)
November 30, 1992... AUTHORS: R. R. MacGregor and A. Graziani. University of Pennsylvania AIDS Clinical Trial Unit, Philadelphia, Pennsylvania. According to an abstract presented to a poster session at the Fifteenth AIDS Clinical Trials Group Meeting,...

Where have all the young men (women, blacks, Hispanics, injection drug users) gone? The gap between a primary care population and clinical trial enrollment. (Research Report)
November 30, 1992... AUTHORS: S.A. Moody, S.H. Cheeseman, J. Avato, C. Jaffarian, C.A. Bova, L. Mangini, E. Cullen, L. Bousquet, A. Molina, R. Ellison, K.K. Lai, D. Margolis, D. Hatem and P.G. Fairchild. University of Massachusetts AIDS Clinical Trial Unit,...

Adolescent outreach: use of a screening questionnaire to identify teens at risk for HIV. (Research Report)
November 30, 1992... AUTHORS: J. Mendel and C. van der Horst. Triad Health Project, Greensboro, North Carolina, and University of North Carolina, Chapel Hill, North Carolina. According to an abstract presented to a poster session at the Fifteenth AIDS...

Central nervous system histopathology in AIDS patients dying with cryptococcal meningitis. (Research Report)
November 30, 1992... AUTHORS: C. van der Horst, B. Alston, L. Flanagan and F. Dalldorf. University of North Carolina, Chapel Hill, North Carolina. According to an abstract presented to a poster session at the Fifteenth AIDS Clinical Trials Group Meeting,...

Adolescent outreach efforts locate and educate high risk teens through multileveled community agency coordination. (Research Report)
November 30, 1992... AUTHORS: W. Lim, J.H. Haggerty and C. van der Horst. University of North Carolina, Chapel Hill, North Carolina. According to an abstract presented to a poster session at the Fifteenth AIDS Clinical Trials Group Meeting, held November...

CD4 count and AIDS dementia complex. (Research Report)
November 30, 1992... AUTHORS: R. Flores, P. Salvato, C. Thompson and S. Stroud. Houston Immunological Institute, Houston, Texas. According to an abstract submitted by the authors to the VIII International Conference on AIDS, held in Amsterdam, The...

Acquired eyelashes hypertrichosis (AEH) in AIDS: causal agent(s)? (Research Report)
November 30, 1992... AUTHORS: T. Gemby, I. Poizot-Martin, C. Farnarier, S. Kaplanski and J. Gastaut. Hopital de Jour (CISIH) Hopital Ste-Marguerite; Institut PAOLI-CAL-METTES, Laboratoire Immunologie, Hopital Ste-Marguerite, Marseille, France. According...

Human herpesvirus 7 is a T-lymphotropic virus and is related to, but significantly different from, human herpesvirus 6 and human cytomegalovirus. (Periodical Report)
November 30, 1992... SOURCE: Proceedings of the National Academy of Sciences, November 1, 1992;89(21):10552-10556. Human herpesvirus 7 (HHV-7) is a T-lymphotropic virus distinct from HHV-6 and human cytomegalovirus (CMV), DNA sequencing and hybridization...

Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)cytosine. (Periodical Report)
November 30, 1992... SOURCE: Antimicrobial Agents and Chemotherapy, November 1992;36(11):2423-2431. A new nucleoside analog is as potent an inhibitor of HIV as zidovudine (AZT) but appears to be far less toxic, laboratory studies show. Moreover, the...

Intracellular zidovudine (ZDV) and ZDV phosphates as measured by a validated combined high-pressure liquid chromatography-radioimmunoassay procedure. (Periodical Report)
November 30, 1992... SOURCE: Antimicrobial Agents and Chemotherapy, November 1992;36(11):2473-2477. A new technique is able to measure the intracellular concentrations of zidovudine (AZT, ZDV) in the peripheral blood mononuclear cells (PBMC) of treated...

A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition. (Periodical Report)
November 30, 1992... SOURCE: Proceedings of the National Academy of Sciences, November 1, 1992;89(21):10537-10541. A peptide synthesized in order to examine the structure of the HIV-1 transmembrane protein has unexpected - and potent - anti-HIV activity...

Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus infection and zidovudine therapy. (Periodical Report)
November 30, 1992... SOURCE: Annals of Internal Medicine, November 1, 1992;117(9):739-748. Anemic patients with AIDS who are receiving zidovudine (AZT) and have low (</=500 IU/L) baseline levels of endogenous erythropoietin benefit from therapy with...

Researchers differ on acyclovir/AZT efficacy. (Fifteenth AIDS Clinical Trials Group meeting)
November 23, 1992... Fifteenth AIDS Clinical Trials Group Meeting Researchers from Australia and Europe say people with AIDS can benefit from adding acyclovir to AZT regimens, but U.S. researchers remain unconvinced. Presentations on clinical trials...

Yeast infections may signal HIV infection. (National Commission on AIDS)
November 23, 1992... National Commission on AIDS Frequent or persistent vaginal yeast infections may be an early warning sign of infection with HIV, health officials warned at the meeting of the National Commission on AIDS, held in Bethesda, Maryland. ...

Experts offer advice on AIDS and TB. (National Commission on AIDS)
November 23, 1992... National Commission on AIDS A Democrat who once headed the government's health department says President-elect Clinton has a moral obligation to put more resources into the fight against AIDS. And former secretary Joseph Califano...

Unsafe sex could lead to more HIV infections among heterosexuals, study says. (National Commission on AIDS)
November 23, 1992... National Commission on AIDS Unprotected sex is so widespread in the United States that an HIV epidemic is on the verge of exploding among heterosexuals, according to a national survey. So many people are having sex with multiple...

Chemists model how HIV mutates. (Penn State University)
November 23, 1992... Penn State University Penn State, University Park, Pennsylvania, chemists have discovered how HIV-1 may develop mutations that contribute to its resistance to AIDS drugs. Working with isolated components of the virus, the chemists...

Two people infected with malaria from blood transfusion. (Texas)
November 23, 1992... Texas Two Dallas patients have been infected with malaria from blood transfusions, including one woman who died last week, health officials said. The cases, the first in Texas since 1985, were traced to a single blood donor, an...

HIV tests taken six years ago lacked effectiveness, study finds. (California)
November 23, 1992... California A study involving stored blood samples shows that earlier tests used to screen for HIV missed half the infections that showed up later using a more up-to-date test. The University of Southern California (USC), Los...

State high court rules in hospital liability case involving blood contamination. (New York)
November 23, 1992... New York Hospital administrators said they are relieved that New York state's highest court has declined to expand their liability for blood and other medical services typically supplied by outside contractors. "We're very happy...

Hospital ordered to hire HIV-infected pharmacist without restrictions on job duties or lose federal funding. (Lambda Legal Defense and Education Fund)
November 23, 1992... Lambda Legal Defense and Education Fund In a reportedly first federal HIV-related civil rights enforcement action, the U.S. Department of Health & Human Services (HHS) ruled that a medical center in New York discriminated against an...

Cost of fighting AIDS staggering for Asian countries. (India)
November 23, 1992... India AIDS, which is spreading faster in Asia than anywhere else, is an economic catastrophe for some of the world's poorest countries, experts said. Governments and businesses must share the cost of fighting the disease or face...

People with HIV protected by state human rights act. (Minnesota Court of Appeals)
November 23, 1992... Minnesota Court of Appeals People in Minnesota who have HIV are protected by anti-discrimination provisions of the state's Human Rights Act, the Minnesota Court of Appeals has ruled. A three-judge panel unanimously ruled that a...

State starting interactive phone line for clinical trials. (New York)
November 23, 1992... New York An interactive telephone line that tells doctors and patients the latest information about drug treatments for people with AIDS or HIV has been started by the New York state Health Department. People who call will be told...

HIV Peer Network provides speakers to address AIDS in the workplace. (New York)
November 23, 1992... New York A new program has been launched to provide targeted AIDS education in the workplace by matching speakers and audiences by profession and industry. The HIV Peer Network is made up of a group of HIV-positive professionals...

Prentice Hall publishes review of AIDS. ("Acquired Immune Deficiency Syndrome: Biological, Medical, Social and Legal Issues" by Gerald J. Stine) (New Jersey)
November 23, 1992... New Jersey Prentice Hall announces the publication of "Acquired Immune Deficiency Syndrome: Biological, Medical, Social and Legal Issues" by Gerald J. Stine. In his new book, Stine offers readers a brief review of the most...

The Expanded Mini-mental Exam: an assessment tool for early detection of subtle cognitive changes in HIV-infected people. (Research Report)
November 23, 1992... AUTHORS: P. Timmons( 1), M. Beitzel( 1) and G. Hollander( 2). (1)Great Lakes Hemophilia Foundation, (2)Sinai Samaritan Medical Center, Milwaukee, Wisconsin. According to an abstract presented to a poster session at the Fifteenth AIDS...

The impact of gastrointestinal side effects on participation in ACTG 175. (AIDS Clinical Trials Group) (Research Report)
November 23, 1992... AUTHORS: M. Royal, M. Gould, G. Kim, M. Klebert, M. McQuire, M. Meyers, A. Slack, T. Stiffler, J. Vorhees and W. Powderly. Washington University AIDS Clinical Trial Unit, St. Louis, Missouri. According to an abstract presented to a...

Monitoring of zidovudine phosphorylation in patients: interim results from ACTG 161. (AIDS Clinical Trials Group) (Research Report)
November 23, 1992... AUTHORS: B. Stretcher, A. Pesce, J. Sanchez, K. Greenburg, P. Hurtubise and P. Frame. University of Cincinnati Medical Center, Cincinnati, Ohio. According to an abstract presented to a poster session at the Fifteenth AIDS Clinical...

Maternal and child services component within adult ACTU improves clinical care and increases patient compliance, enrollment and retention in clinical trials. (AIDS Clinical Trials Unit) (Research Report)
November 23, 1992... AUTHORS: W. Lim, J.H. Haggerty and C. van der Horst. University of North Carolina, Chapel Hill, North Carolina. According to an abstract presented to a poster session at the Fifteenth AIDS Clinical Trials Group Meeting, held November...

Experience with cryptococcosis in African-American patients. (Research Report)
November 23, 1992... AUTHORS: B. Peters, W. Greaves, J. Bruce, R. Delapenha, L. Olopoenia and W. Frederick. Howard University Hospital, Washington, D.C. According to an abstract submitted by the authors to the VIII International Conference on AIDS, held...

Toxoplasmosis in Indian AIDS patients. (Research Report)
November 23, 1992... AUTHORS: S. Sarman, P. Seth and J. Dubey. All India Institute of Medical Sciences, New Delhi, India; Protozoan Diseases Laboratory, ARS, United States Department of Agriculture, BARC, Beltsville, Maryland. According to an abstract...

Development of dental services for HIV/AIDS patients in San Juan, Puerto Rico. (Research Report)
November 23, 1992... AUTHORS: J. Maldonado-Moll, Y. Kouri and S. Tollinche. San Juan AIDS Institute, San Juan, Puerto Rico. According to an abstract submitted by the authors to the VIII International Conference on AIDS, held in Amsterdam, the Netherlands,...

Transfusion recipient Look Back reassessed: the declining efficacy of health department-blood bank exchange of AIDS case lists. (Research Report)
November 23, 1992... AUTHORS: S. Samson, R. Edmiston, M.P. Busch, E. Nash and H.A. Perkins. Irwin Memorial Blood Centers, San Francisco, California. According to the authors' abstract submitted to the 45th Annual Meeting of the American Association of...

Re-evaluation of anti-HIV seroprevalence among blood donors with contemporary screening assays. (Research Report)
November 23, 1992... AUTHORS: M.J. Nowicki. Transfusion Safety Study Group, University of Southern California, Los Angeles, California, and other participating institutions. According to the author's abstract submitted to the 45th Annual Meeting of the...

Comparison of FDA-recommended and alternative algorithms for confirmation of HIV-1/HIV-2 EIA repeat reactives. (enzyme immunoassay) (Research Report)
November 23, 1992... AUTHORS: P. Stewart and M. Wandell. Genetic Systems Corporation, Redmond, Washington. According to the authors' abstract submitted to the 45th Annual Meeting of the American Association of Blood Banks, held in San Francisco,...

Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus. (Periodical Report)
November 23, 1992... SOURCE: Journal of Acquired Immune Deficiency Syndromes, November 1992;5(11):1069-1074. Sight-threatening cytomegalovirus (CMV) retinitis -perhaps the most feared complication of AIDS - is most likely to develop in individuals whose...

AIDS incidence and income. (Periodical Report)
November 23, 1992... SOURCE: Journal of Acquired Immune Deficiency Syndromes, November 1992;5(11):1105-1110. Poor and minority populations do not benefit from improvements in the treatment of HIV disease, according to a study of AIDS incidence and income...

Inhibition of human immunodeficiency virus type 1 replication in human T cells by retroviral-mediated gene transfer of a dominant-negative Rev trans-activator. (Periodical Report)
November 23, 1992... SOURCE: Proceedings of the National Academy of Sciences, October 15, 1992;89(20):9870-9874. Human T cells genetically engineered to express a mutant form of the HIV-1 rev gene are invulnerable to the cytopathic effects of HIV-1...

Cloning and chromosomal mapping of a human immunodeficiency virus 1 'TATA' element modulatory factor. (Periodical Report)
November 23, 1992... SOURCE: Proceedings of the National Academy of Sciences, October 15, 1992;89(20):9372-9376. Researchers report the identification of a cellular protein that inhibits the expression of HIV genes. The protein appears to be an...

Clinical trial of tat inhibitor to begin. (Hoffmann-La Roche's Ro 24-7429) (Fifteenth National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Meeting)
November 16, 1992... The long-awaited Phase I/II clinical trial of a new type of anti-HIV drug is set to begin, investigators announced at the AIDS Clinical Trials Group (ACTG) meeting held November 3-6, 1992, in Washington, D.C. The drug, code-named Ro...

U.S. trial of protease inhibitor set to begin. (Hoffmann-La Roche's Ro 31-8959) (Fifteenth National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Meeting)
November 16, 1992... The first U.S. clinical trial of an HIV protease inhibitor is set to begin, researchers announced at the AIDS Clinical Trials Group (ACTG) meeting held November 3-6, 1992, in Washington, D.C. The drug, Ro 31-8959, is manufactured by...

"Convergent multidrug therapy" proposed. (Fifteenth National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Meeting)
November 16, 1992... A combination of currently available drugs might overcome the ability of HIV to develop resistance to antiviral agents, a researcher suggested at the AIDS Clinical Trials Group (ACTG) meeting held November 3-6, 1992, in Washington, D.C. ...

Pharmaceutical Industry Advisory Panel sets goals. (Fifteenth National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Meeting)
November 16, 1992... The central point of contention between the pharmaceutical industry and the U.S. National Institute of Allergy and Infectious Diseases (NIAID) is access to data, the chair of an industry panel said at the AIDS Clinical Trials Group (ACTG)...

Study launched on ICL and blood transfusions. (idiopathic CD4 T-lymphocytopenia) (American Association of Blood Banks)
November 16, 1992... The U.S. government is launching a study to determine whether a mysterious, AIDS-like illness can be transmitted by blood transfusion, researchers said. The study is being undertaken even though researchers believe there is almost no...

CDC study documents small risk of HIV transmission by transfusion. (Centers for Disease Control and Prevention) (American Association of Blood Banks)
November 16, 1992... According to research presented at the 45th Annual Meeting of the American Association of Blood Banks (AABB) in San Francisco, November 7-12, 1992, the risk to patients of acquiring HIV from a screened unit of blood is extremely low. ...

Surveillance study finds no HIV-1 antigen positive, antibody negative blood donors. (American Association of Blood Banks)
November 16, 1992... An ongoing surveillance study has not isolated any HIV-1 antibody negative blood donors who tested positive on the p24 antigen assay, supporting current evidence that use of this screening test would not add to the safety of the blood...

Study shows decline in HIV prevalence among blood donors. (American Association of Blood Banks)
November 16, 1992... A new study shows evidence that HIV prevalence among blood donors continues to decline, according to research presented at the 45th Annual Meeting of the American Association of Blood Banks (AABB) in San Francisco, November 7-12, 1992. ...

"Molecular knife" to be tried against HIV in humans. (hairpin ribozyme) (University of California, San Diego)
November 16, 1992... Scientists developed a tiny "molecular knife" that cuts and destroys part of HIV, and they soon will test the treatment on people with the disease, a researcher said. "It's a new technology which could potentially be very powerful, but...

AIDS conference opens in New Delhi. (India)
November 16, 1992... An Asian-Pacific conference on AIDS opened in New Delhi, India, on November 8, 1992, with Indian Vice President Kocheril R. Narayanan calling for increased public awareness to help remove the social stigma attached to the disease. The...

Committee raps Congress on vaccine testing. (MicroGeneSys Inc.'s gp160 AIDS vaccine) (U.S. National Institutes of Health AIDS Program Advisory Committee)
November 16, 1992... A U.S. National Institutes of Health (NIH) committee criticized the U.S. Congress for requiring tests of an AIDS vaccine, saying such a widespread trial is inappropriate. Dr. Charles C.J. Carpenter, a Brown University professor and...

Employers allowed to change insurance coverages. (U.S. Supreme Court)
November 16, 1992... The U.S. Supreme Court on November 9, 1992, refused to let AIDS patients use a federal pension-protecting law to sue when their employers change healthcare plans to escape costs of treating the disease. The court, over two dissenting...

Government testing immigrants for AIDS/HIV. (Israel)
November 16, 1992... Israel will require foreign workers to be tested for HIV starting January 1, 1993, and has been screening some Jewish immigrants during the past six months, an official said. The disclosure by David Efrati, director of population...

Tainted blood scandal widens to prisons. (prisoners recruited as blood donors) (France)
November 16, 1992... French blood banks continued seeking donations from inmates years after being warned that prisons had large populations with a high risk of HIV infection, according to a government report. One prison was still collecting blood as late...

Hemophiliacs say bureaucratic delays led to HIV infections. (Canada)
November 16, 1992... Bureaucratic delays in implementing blood screening rules led to infection of hemophiliacs with HIV, the Canadian Hemophilia Society said November 6, 1992. However, there was no scandal of a criminal nature such as the one sweeping...

Search for medicines turns seaward. (marine microorganisms being collected & tested) (Scripps Institution of Oceanography, La Jolla, California)
November 16, 1992... Scientists are turning from the land to the sea to discover new sources of drugs to fight cancer, AIDS and other diseases, a researcher said. "Despite an investment of around $10 billion per year by the drug industry, we are realizing...

Company commercializes its first product for determining TB therapy compliance. (Mycodyn Uritec urine test) (DynaGen Inc.)
November 16, 1992... DynaGen Inc., Cambridge, Massachusetts, announced that it has begun commercial sales of its Mycodyn Uritec diagnostic strip test, a simple urine test for determining compliance to tuberculosis (TB) drug therapy. Public health...

Bar association recommends law changes for AIDS patients. (New York)
November 16, 1992... Recommendations that would change New York state laws to show more compassion for convicts with AIDS and give greater legal rights to homosexuals drew mixed reaction from officials. The recommendations from a New York State Bar...

Experts urge expansion of anonymous HIV testing program. (Colorado)
November 16, 1992... The results of an experimental program that provides anonymous HIV blood tests indicate the program is making an impact on the Denver, Colorado, AIDS community and should be expanded, advocates and experts said. The anonymous testing...

Increase in AIDS cases among non-gay drug addicts draws concern. (California)
November 16, 1992... An increase in AIDS cases among non-gay drug addicts and their sex partners has prompted a San Diego, California, health official to urge the county to make a better effort to prevent HIV from spreading. "We're very concerned about a...

Study shows African-American gay/bisexual men still at high AIDS risk. (University of California, San Francisco)
November 16, 1992... Gay and bisexual African-American men are practicing high-risk sexual behavior at higher rates than white gay men, according to a University of California, San Francisco (UCSF), report. The study, which included 250 gay and bisexual...

Cat-scratch organism implicated in AIDS encephalopathy. (Rochalimaea henselae) (California)
November 16, 1992... Rochalimaea henselae (R. henselae), a recently identified organism associated with cat-scratch disease, has now been implicated as a likely cause of acute disorientation, hallucinations and rapidly progressive dementia in patients with AIDS....

Company files product license application for pediatric HIV therapy. (Gamimune-N intravenous immunoglobulin) (Miles Inc.)
November 16, 1992... The Biological Products Unit of Miles Inc., West Haven, Connecticut, announced that it has filed a Product License Application (PLA) with the U.S. Food and Drug Administration (FDA) for Gamimune-N, an intravenous immunoglobulin (IVIG) to...

p-ANCA in HIV-infected patients - association with opportunistic diseases. (antineutrophil cytoplasmic autoantibodies of the perinuclear type) (Research Report)
November 16, 1992... AUTHORS: O. Cornely, B. Salzberger, G. Fatkenheuer, R. Klein, P. Berg, V. Diehl and M. Schrappe. Department of Internal Medicine, University of Cologne; Department of Internal Medicine, Tubingen; Germany. According to an abstract...

Recombinant immunoblot assay (RIBA) versus conventional Western blot analysis for the diagnosis and distinction of HIV-1 and HIV-2 infections. (Research Report)
November 16, 1992... AUTHORS: M. Gutierrez, V. Soriano, P. Martinez-Acacio, A. Polito, F. Fumanal, M. Baquero and J. Gonzalez-Lahoz. Centro de Investigacion Clinica, Instituto de Salud Carlos III, Madrid, Spain; Chiron Corporation, Emeryville, California. ...